-
Electronic (PDF)
-
Site License
-
Enterprisewide
Israel Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2015
Global Markets Direct, September 2009, Pages: 60
Israel Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2015
Summary
This report is an essential source for in-depth information and data relating to Israel drug delivery devices market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and the latest news, financial deals and pipeline products information of each of the key sub-segments of the drug delivery devices market in Israel
Scope
- The report provides information on the drug delivery devices market in Israel.
- Details on the key segments and categories such as Inhalation Systems, Needle Free Injections, and Infusion Systems.
- Total revenues, products sold, end users, and average pricing.
- Market shares of all the key competitors such as GlaxoSmithKline plc, AstraZeneca International plc, Boehringer Ingelheim GmbH, Novartis AG, and Fresenius Kabi AG.
- Key pipeline products that are set to shape the market, broken down by sector.
- Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
- Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
- Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
- Key mergers and acquisitions, partnerships, private equity investments and IPOs.
- Customer, hospitals and physicians data.
Reasons to buy
- Gain a strong understanding of the drug delivery devices market in Israel.
- Evaluate and compare the attractiveness of the market in the country.
- Identify growth segments and opportunities in each industry sector within the country.
- Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
- Analyze the competitiveness of the market in the country and identify hotspots.
- Develop strategies based on the latest product, brand, expansion and research and development news in the country.
- Plan deal strategies with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
- Identify and analyze the strengths and weaknesses of the industry incumbents in the country.
1
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
3 Definitions of the Markets Covered in the Report
3.1 Drug Delivery Devices
3.2 Inhalation Systems
3.2.1 Metered Dose Inhaler
3.2.2 Dry Powder Inhaler
3.3 Infusion Systems
3.3.1 Infusion Pumps
3.3.2 Syringe Pumps
3.3.3 Disposable Infusion Sets
4 Healthcare Sector Review
4.1 Healthcare Sector Review
4.2 Healthcare Expenditure
5 Regulation System
5.1 Regulatory System
5.2 Registration
5.3 Standards
5.4 Customs Duties
5.5 Labeling
6 Pricing and Reimbursement
7 Distribution Structure
8 Drug Delivery Devices In Israel
8.1 Drug Delivery Devices, Israel, Overall Revenue ($ mn), 2000-2015
8.2 Drug Delivery Devices, Israel, Category Volume (Units), 2000-2015
8.3 Drug Delivery Devices, Israel, Company Share (2007-2008)
9 Infusion Systems In Israel
9.1 Infusion Systems Overall Revenue (2000-2015)
9.2 Infusion Systems Overall Volume (2000-2015)
9.3 Infusion Systems Average Price (2000-2015)
9.4 Infusion Systems Distribution Share (2007-2008)
9.5 Infusion Systems, Israel, Company Share (2007-2008)
10 Inhalation Systems In Israel
10.1 Inhalation Systems Overall Revenue (2000-2015)
10.2 Inhalation Systems Overall Volume (2000-2015)
10.3 Inhalation Systems Average Price (2000-2015)
10.4 Inhalation Systems Distribution Share (2007-2008)
10.5 Inhalation Systems, Israel, Company Share (2007-2008)
11 Overview of Key Companies in Israel Drug Delivery Devices Market
11.1 Terumo Corporation
11.1.1 Company Overview
11.2 Smiths Medical
11.2.1 Company Overview
11.3 Novartis AG
11.3.1 Company Overview
11.4 Hospira, Inc.
11.4.1 Company Overview
11.5 GlaxoSmithKline plc
11.5.1 Company Overview
11.6 Fresenius Kabi AG
11.6.1 Company Overview
11.7 Cardinal Health, Inc.
11.7.1 Company Overview
11.8 Boehringer Ingelheim GmbH
11.8.1 Company Overview
11.9 Consort Medical plc
11.9.1 Company Overview
11.9.2 Bespak plc Pipeline Products
11.9.2.1 Bespak plc Pipeline Products By Equipment Type
11.9.2.2 Bespak plc Pipeline Products By Development Stage
11.9.2.3 Bespak plc Pipeline Products By Therapy Area
11.10 Baxter International Inc.
11.10.1 Company Overview
11.11 B. Braun Melsungen AG
11.11.1 Company Overview
11.12 AstraZeneca PLC
11.12.1 Company Overview
11.13 SpiroJet Medical Ltd.
11.13.1 Company Overview
11.14 E-Pill Pharma Ltd.
11.14.1 Company Overview
11.15 Elcam Medical
11.15.1 Company Overview
11.16 Meytav Technological Incubator
11.16.1 Company Overview
11.17 SteadyMed Ltd.
11.17.1 Company Overview
11.17.2 SteadyMed Ltd. Pipeline Products
11.17.2.1 SteadyMed Ltd. Pipeline Products By Equipment Type
11.17.2.2 SteadyMed Ltd. Pipeline Products By Development Stage
11.17.2.3 SteadyMed Ltd. Pipeline Products By Therapy Area
11.17.2.4 SteadyMed Ltd. Pipeline Products By News Summary
11.18 Maya Biotech Ltd.
11.18.1 Company Overview
11.18.2 Maya Biotech Ltd. Pipeline Products
11.18.2.1 Maya Biotech Ltd. Pipeline Products By Equipment Type
11.18.2.2 Maya Biotech Ltd. Pipeline Products By Development Stage
11.18.2.3 Maya Biotech Ltd. Pipeline Products By Therapy Area
11.19 RescueDose L.T.D.
11.19.1 Company Overview
11.19.2 RescueDose L.T.D. Pipeline Products
11.19.2.1 RescueDose L.T.D. Pipeline Products By Equipment Type
11.19.2.2 RescueDose L.T.D. Pipeline Products By Development Stage
11.19.2.3 RescueDose L.T.D. Pipeline Products By Therapy Area
11.20 Medihale Ltd.
11.20.1 Company Overview
11.20.2 Medihale Ltd. Pipeline Products
11.20.2.1 Medihale Ltd. Pipeline Products By Equipment Type
11.20.2.2 Medihale Ltd. Pipeline Products By Development Stage
11.20.2.3 Medihale Ltd. Pipeline Products By Therapy Area
12 Appendix
12.1 Global Markets Direct Research Methodology
12.2 Secondary Research
12.3 Primary Research
12.4 Models
12.5 Forecasts
12.6 Expert Panel Validation
12.7 Currency Conversion
12.8 Contact Us
12.9 Disclaimer
Executive Summary
1.1 List of Tables
Table 1: Total Healthcare Expenditure, Israel, 2000 - 2007 14
Table 2: Drug Delivery Devices, Israel, Overall Revenue ($ mn), 2000-2015 20
Table 3: Drug Delivery Devices, Israel, Cross-Category Analysis, 2000-2015 21
Table 4: Drug Delivery Devices, Israel, Overall Revenue ($ mn), Historic, 2000-2008 22
Table 5: Drug Delivery Devices, Israel, Overall Revenue ($ mn), Forecast, 2008-2015 23
Table 6: Drug Delivery Devices, Israel, Category Volume (Units), 2000-2015 24
Table 7: Drug Delivery Devices, Israel, Category Volume (Units), Historic, 2000-2008 25
Table 8: Drug Delivery Devices, Israel, Category Volume (Units), Forecast, 2008-2015 26
Table 9: Drug Delivery Devices, Israel, Company Share by Revenue ($ mn), 2007-2008 27
Table 10: Infusion Systems, Israel, Revenue ($ mn) by Segment, Historic, 2000-2008 28
Table 11: Infusion Systems, Israel, Revenue ($ mn) by Segment, Forecast, 2008-2015 29
Table 12: Infusion Systems, Israel, Volume (Units) by Segment, Historic, 2000-2008 30
Table 13: Infusion Systems, Israel, Volume (Units) by Segment, Forecast, 2008-2015 30
Table 14: Infusion Systems, Israel, Average Price ($), Historic, 2000-2008 31
Table 15: Infusion Systems, Israel, Average Price ($), Forecast, 2008-2015 31
Table 16: Infusion Systems, Israel, Distribution Share by Revenue ($mn), 2007-2008 32
Table 17: Infusion Systems, Israel, Company Share by Revenue ($ mn), 2007-2008 33
Table 18: Inhalation Systems, Israel, Revenue ($ mn) by Segment, Historic, 2000-2008 34
Table 19: Inhalation Systems, Israel, Revenue ($ mn) by Segment, Forecast, 2008-2015 35
Table 20: Inhalation Systems, Israel, Volume (Units) by Segment, Historic, 2000-2008 36
Table 21: Inhalation Systems, Israel, Volume (Units) by Segment, Forecast, 2008-2015 37
Table 22: Inhalation Systems, Israel, Average Price ($), Historic, 2000-2008 38
Table 23: Inhalation Systems, Israel, Average Price ($), Forecast, 2008-2015 38
Table 24: Inhalation Systems, Israel, Distribution Share by Revenue ($mn), 2007-2008 39
Table 25: Inhalation Systems, Israel, Company Share by Revenue ($ mn), 2007-2008 40
Table 26: Bespak plc Pipeline Products by Equipment Type 46
Table 27: Bespak plc Pipeline Products By Development Stage 46
Table 28: Bespak plc Pipeline Products By Therapy Area 46
Table 29: SteadyMed Ltd. Pipeline Products by Equipment Type 50
Table 30: SteadyMed Ltd. Pipeline Products By Development Stage 50
Table 31: SteadyMed Ltd. Pipeline Products By Therapy Area 50
Table 32: SteadyMed Ltd. Pipeline Products By News Summary 51
Table 33: Maya Biotech Ltd. Pipeline Products by Equipment Type 52
Table 34: Maya Biotech Ltd. Pipeline Products By Development Stage 52
Table 35: Maya Biotech Ltd. Pipeline Products By Therapy Area 52
Table 36: RescueDose L.T.D. Pipeline Products by Equipment Type 53
Table 37: RescueDose L.T.D. Pipeline Products By Development Stage 53
Table 38: RescueDose L.T.D. Pipeline Products By Therapy Area 54
Table 39: Medihale Ltd. Pipeline Products by Equipment Type 55
Table 40: Medihale Ltd. Pipeline Products By Development Stage 55
Table 41: Medihale Ltd. Pipeline Products By Therapy Area 55
Table 42: USD to Local Currency, Average Exchange Rate 2008 59
Terumo Corporation
Smiths Medical
Novartis AG
Hospira, Inc.
GlaxoSmithKline plc
Fresenius Kabi AG
Cardinal Health, Inc.
Boehringer Ingelheim GmbH
Consort Medical plc
Baxter International Inc.
B. Braun Melsungen AG
AstraZeneca PLC
SpiroJet Medical Ltd.
E-Pill Pharma Ltd.
Elcam Medical
Meytav Technological Incubator
SteadyMed Ltd.
Maya Biotech Ltd.
RescueDose L.T.D.
Medihale Ltd.
Customers who bought this item also bought
All rights reserved. © Copyright 2013 Research and Markets WWW5
Terms and Conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network
